Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

Identifieur interne : 000577 ( Main/Exploration ); précédent : 000576; suivant : 000578

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

Auteurs : Ying Jiao Zhao ; Hwee Lin Wee ; Yiong-Huak Chan ; Soo Hoon Seah ; Wing Lok Au ; Puay Ngoh Lau ; Emmanuel Camara Pica ; Shu Chuen Li [Australie] ; Nan Luo ; Louis C. S. Tan

Source :

RBID : ISTEX:E1422341D7A6410CBC1BB6EFAAB4DCE50B10AB3D

English descriptors

Abstract

This study was carried out to evaluate progression in Parkinson's disease (PD) by analyzing time taken to transit from one Hoehn and Yahr (H&Y) stage to the next stage and to investigate the variables that would be associated with H&Y transition times using a large PD database that contained prospectively collected information. Data were obtained from the movement disorder database of the National Neuroscience Institute in Singapore. Kaplan‐Meier (KM) survival analysis was adopted to investigate the time taken to progress through various H&Y stages. Cox regression analysis was used to examine the association between the baseline variables at the entry point of each H&Y stage and the progression to the next stage. A total of 695 patients (mean age: 65.2, male: 57.3%) were studied. Using KM analysis, the median time taken to transit from H&Y stage 1 to 2, 2 to 2.5, 2.5 to 3 were 20, 62, and 25 months, respectively; whereas the median time taken to progress from stage 3 to 4 and 4 to 5 were 24 and 26 months, respectively. Cox regression analysis revealed that older age‐at‐diagnosis, longer PD duration, and higher Unified Parkinson's Disease Rating Scale (UPDRS) motor scores at baseline were associated with a significantly faster progression through various H&Y stages. Gender and ethnicity were not associated with disease progression. In conclusion, H&Y transition time is a useful measure of disease progression in PD and may be utilized in clinical studies evaluating therapeutic interventions and prognostic factors in PD. © 2010 Movement Disorder Society

Url:
DOI: 10.1002/mds.22875


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times</title>
<author>
<name sortKey="Zhao, Ying Jiao" sort="Zhao, Ying Jiao" uniqKey="Zhao Y" first="Ying Jiao" last="Zhao">Ying Jiao Zhao</name>
</author>
<author>
<name sortKey="Wee, Hwee Lin" sort="Wee, Hwee Lin" uniqKey="Wee H" first="Hwee Lin" last="Wee">Hwee Lin Wee</name>
</author>
<author>
<name sortKey="Chan, Yiong Uak" sort="Chan, Yiong Uak" uniqKey="Chan Y" first="Yiong-Huak" last="Chan">Yiong-Huak Chan</name>
</author>
<author>
<name sortKey="Seah, Soo Hoon" sort="Seah, Soo Hoon" uniqKey="Seah S" first="Soo Hoon" last="Seah">Soo Hoon Seah</name>
</author>
<author>
<name sortKey="Au, Wing Lok" sort="Au, Wing Lok" uniqKey="Au W" first="Wing Lok" last="Au">Wing Lok Au</name>
</author>
<author>
<name sortKey="Lau, Puay Ngoh" sort="Lau, Puay Ngoh" uniqKey="Lau P" first="Puay Ngoh" last="Lau">Puay Ngoh Lau</name>
</author>
<author>
<name sortKey="Pica, Emmanuel Camara" sort="Pica, Emmanuel Camara" uniqKey="Pica E" first="Emmanuel Camara" last="Pica">Emmanuel Camara Pica</name>
</author>
<author>
<name sortKey="Li, Shu Chuen" sort="Li, Shu Chuen" uniqKey="Li S" first="Shu Chuen" last="Li">Shu Chuen Li</name>
</author>
<author>
<name sortKey="Luo, Nan" sort="Luo, Nan" uniqKey="Luo N" first="Nan" last="Luo">Nan Luo</name>
</author>
<author>
<name sortKey="Tan, Louis C S" sort="Tan, Louis C S" uniqKey="Tan L" first="Louis C. S." last="Tan">Louis C. S. Tan</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E1422341D7A6410CBC1BB6EFAAB4DCE50B10AB3D</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.22875</idno>
<idno type="url">https://api.istex.fr/document/E1422341D7A6410CBC1BB6EFAAB4DCE50B10AB3D/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000135</idno>
<idno type="wicri:Area/Main/Curation">000113</idno>
<idno type="wicri:Area/Main/Exploration">000577</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times</title>
<author>
<name sortKey="Zhao, Ying Jiao" sort="Zhao, Ying Jiao" uniqKey="Zhao Y" first="Ying Jiao" last="Zhao">Ying Jiao Zhao</name>
<affiliation>
<wicri:noCountry code="subField">Republic of Singapore</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Wee, Hwee Lin" sort="Wee, Hwee Lin" uniqKey="Wee H" first="Hwee Lin" last="Wee">Hwee Lin Wee</name>
<affiliation>
<wicri:noCountry code="subField">Republic of Singapore</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Chan, Yiong Uak" sort="Chan, Yiong Uak" uniqKey="Chan Y" first="Yiong-Huak" last="Chan">Yiong-Huak Chan</name>
<affiliation>
<wicri:noCountry code="subField">Republic of Singapore</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Seah, Soo Hoon" sort="Seah, Soo Hoon" uniqKey="Seah S" first="Soo Hoon" last="Seah">Soo Hoon Seah</name>
<affiliation>
<wicri:noCountry code="subField">National Parkinson Foundation International Centre of Excellence</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Au, Wing Lok" sort="Au, Wing Lok" uniqKey="Au W" first="Wing Lok" last="Au">Wing Lok Au</name>
<affiliation>
<wicri:noCountry code="subField">National Parkinson Foundation International Centre of Excellence</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Lau, Puay Ngoh" sort="Lau, Puay Ngoh" uniqKey="Lau P" first="Puay Ngoh" last="Lau">Puay Ngoh Lau</name>
<affiliation>
<wicri:noCountry code="subField">National Parkinson Foundation International Centre of Excellence</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Pica, Emmanuel Camara" sort="Pica, Emmanuel Camara" uniqKey="Pica E" first="Emmanuel Camara" last="Pica">Emmanuel Camara Pica</name>
<affiliation>
<wicri:noCountry code="subField">National Parkinson Foundation International Centre of Excellence</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Li, Shu Chuen" sort="Li, Shu Chuen" uniqKey="Li S" first="Shu Chuen" last="Li">Shu Chuen Li</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Discipline of Pharmacy & Experimental Pharmacology, School of Biomedical Sciences, University of Newcastle</wicri:regionArea>
<wicri:noRegion>University of Newcastle</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Luo, Nan" sort="Luo, Nan" uniqKey="Luo N" first="Nan" last="Luo">Nan Luo</name>
<affiliation>
<wicri:noCountry code="subField">Republic of Singapore</wicri:noCountry>
</affiliation>
<affiliation>
<wicri:noCountry code="subField">Republic of Singapore</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Tan, Louis C S" sort="Tan, Louis C S" uniqKey="Tan L" first="Louis C. S." last="Tan">Louis C. S. Tan</name>
<affiliation>
<wicri:noCountry code="subField">National Parkinson Foundation International Centre of Excellence</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-04-30">2010-04-30</date>
<biblScope unit="volume">25</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="710">710</biblScope>
<biblScope unit="page" to="716">716</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">E1422341D7A6410CBC1BB6EFAAB4DCE50B10AB3D</idno>
<idno type="DOI">10.1002/mds.22875</idno>
<idno type="ArticleID">MDS22875</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>H&Y</term>
<term>Parkinson's disease</term>
<term>progression</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">This study was carried out to evaluate progression in Parkinson's disease (PD) by analyzing time taken to transit from one Hoehn and Yahr (H&Y) stage to the next stage and to investigate the variables that would be associated with H&Y transition times using a large PD database that contained prospectively collected information. Data were obtained from the movement disorder database of the National Neuroscience Institute in Singapore. Kaplan‐Meier (KM) survival analysis was adopted to investigate the time taken to progress through various H&Y stages. Cox regression analysis was used to examine the association between the baseline variables at the entry point of each H&Y stage and the progression to the next stage. A total of 695 patients (mean age: 65.2, male: 57.3%) were studied. Using KM analysis, the median time taken to transit from H&Y stage 1 to 2, 2 to 2.5, 2.5 to 3 were 20, 62, and 25 months, respectively; whereas the median time taken to progress from stage 3 to 4 and 4 to 5 were 24 and 26 months, respectively. Cox regression analysis revealed that older age‐at‐diagnosis, longer PD duration, and higher Unified Parkinson's Disease Rating Scale (UPDRS) motor scores at baseline were associated with a significantly faster progression through various H&Y stages. Gender and ethnicity were not associated with disease progression. In conclusion, H&Y transition time is a useful measure of disease progression in PD and may be utilized in clinical studies evaluating therapeutic interventions and prognostic factors in PD. © 2010 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Au, Wing Lok" sort="Au, Wing Lok" uniqKey="Au W" first="Wing Lok" last="Au">Wing Lok Au</name>
<name sortKey="Chan, Yiong Uak" sort="Chan, Yiong Uak" uniqKey="Chan Y" first="Yiong-Huak" last="Chan">Yiong-Huak Chan</name>
<name sortKey="Lau, Puay Ngoh" sort="Lau, Puay Ngoh" uniqKey="Lau P" first="Puay Ngoh" last="Lau">Puay Ngoh Lau</name>
<name sortKey="Luo, Nan" sort="Luo, Nan" uniqKey="Luo N" first="Nan" last="Luo">Nan Luo</name>
<name sortKey="Pica, Emmanuel Camara" sort="Pica, Emmanuel Camara" uniqKey="Pica E" first="Emmanuel Camara" last="Pica">Emmanuel Camara Pica</name>
<name sortKey="Seah, Soo Hoon" sort="Seah, Soo Hoon" uniqKey="Seah S" first="Soo Hoon" last="Seah">Soo Hoon Seah</name>
<name sortKey="Tan, Louis C S" sort="Tan, Louis C S" uniqKey="Tan L" first="Louis C. S." last="Tan">Louis C. S. Tan</name>
<name sortKey="Wee, Hwee Lin" sort="Wee, Hwee Lin" uniqKey="Wee H" first="Hwee Lin" last="Wee">Hwee Lin Wee</name>
<name sortKey="Zhao, Ying Jiao" sort="Zhao, Ying Jiao" uniqKey="Zhao Y" first="Ying Jiao" last="Zhao">Ying Jiao Zhao</name>
</noCountry>
<country name="Australie">
<noRegion>
<name sortKey="Li, Shu Chuen" sort="Li, Shu Chuen" uniqKey="Li S" first="Shu Chuen" last="Li">Shu Chuen Li</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000577 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000577 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:E1422341D7A6410CBC1BB6EFAAB4DCE50B10AB3D
   |texte=   Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024